LNWTC
RDY icon

Laird Norton Wetherby Trust Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Buy
272,486
+8,756
+3% +$122K 0.08% 195
2025
Q4 		$3.7M Buy
+263,730
New +$3.7M 0.08% 199

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Laird Norton Wetherby Trust Company's RDY Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company increased its Dr. Reddy's Laboratories (RDY) stake by 3.3% in Q1 2026, buying an estimated $122K and bringing the position to 272,486 shares worth $3.77M. The position accounts for 0.08% of the portfolio, ranked #195.

Laird Norton Wetherby Trust Company first reported a position in RDY in Q4 2025 and has held it in 2 quarters since. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 272,486 shares of Dr. Reddy's Laboratories worth $3.77M as of Q1 2026.
  • Laird Norton Wetherby Trust Company bought 8,756 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $122K.
  • Dr. Reddy's Laboratories made up 0.08% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #195 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.